Overexpression of SOX2 can be seen in CRC [6]–[8] as well as in several other malignancies such as breast, pancreatic and gastric cancers [9]–[11], demonstrating its involvement in carcinogenesis. Here, SOX2 is linked to colorectal carcinoma.